Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Ulcerative Colitis (UC)Crohn's DiseaseInflammatory Bowel Disease (IBD)

Interventions

OTHER

Discontinuation of 5-ASA

Discontinuation of 5-ASA from the time of study enrollment.

All Listed Sponsors

lead

Pusan National University Hospital

OTHER

NCT06878495 - Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter